Notably, in patients with severe COVID-19, the proportion of PD-1 positive CD4 cells was elevated over those in the non-severe group and HCs at 2-4 weeks (Figure 3A, P < 0.05 and P < 0.01, respectively). This evidence concerns the gene CD4 and COVID-19.